{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:37:22Z","timestamp":1790753842616,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Ovarian cancers are curable by surgical resection when discovered early. Unfortunately, most ovarian cancers are diagnosed in the later stages. One strategy to identify early ovarian tumors is to screen women who have the highest risk. This opinion article summarizes the accuracy of different methods used to assess the risk of developing ovarian cancer, including family history, BRCA genetic tests, and polygenic risk scores. The accuracy of these is compared to the maximum theoretical accuracy, revealing a substantial gap. We suggest that this gap, or missing heritability, could be caused by epistatic interactions between genes. An alternative approach to computing genetic risk scores, using chromosomal-scale length variation should incorporate epistatic interactions. Future research in this area should focus on this and other alternative methods of characterizing genomes.<\/jats:p>","DOI":"10.3390\/genes14030762","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T06:56:48Z","timestamp":1679381808000},"page":"762","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic Risk Scores and Missing Heritability in Ovarian Cancer"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8660-1621","authenticated-orcid":false,"given":"Yasaman","family":"Fatapour","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, University of California, Irvine, CA 92697, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Brody","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of California, Irvine, CA 92697, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2017.21926","article-title":"Screening for ovarian cancer US preventive services task force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","article-title":"The Contribution of BRCA1 and BRCA2 to Ovarian Cancer","volume":"3","author":"Ramus","year":"2009","journal-title":"Mol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzler, K.W., Velculescu, V., Vogelstein, B., and Nowak, M.A. (2007). Genetic Progression and the Waiting Time to Cancer. PLoS Comput. Biol., 3.","DOI":"10.1371\/journal.pcbi.0030225"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1142\/S1793048014500015","article-title":"The Age Specific Incidence Anomaly Suggests that Cancers Originate During Development","volume":"9","author":"Brody","year":"2014","journal-title":"Biophys. Rev. Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ng1205","article-title":"Have environmental mutagens caused oncomutations in people?","volume":"34","author":"Thilly","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1373\/clinchem.2012.182550","article-title":"Quantifying the Added Value of a Diagnostic Test or Marker","volume":"58","author":"Moons","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_8","first-page":"S83","article-title":"Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: Communicating the performance of diagnostic tests","volume":"29","author":"Florkowski","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"ref_9","first-page":"395","article-title":"Predictive testing for complex diseases using multiple genes: Fact or fiction? Genetics in Medicine","volume":"8","author":"Janssens","year":"2006","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial Risk and Heritability of Cancer Among Twins in Nordic Countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"ref_11","first-page":"1879","article-title":"Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually","volume":"81","author":"Gail","year":"1989","journal-title":"Gynecol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/jnci\/djm224","article-title":"Predicting risk of breast cancer in postmen-opausal women by hormone receptor status","volume":"99","author":"Chlebowski","year":"2007","journal-title":"J. Natl. Cancer. Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat. Med."},{"key":"ref_14","first-page":"489","article-title":"Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort","volume":"112","author":"McCarthy","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cge.13566","article-title":"Epithelial ovarian cancer risk: A review of the current genetic landscape","volume":"97","author":"Flaum","year":"2020","journal-title":"Clin. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","article-title":"The personal and clinical utility of polygenic risk scores","volume":"19","author":"Torkamani","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: From research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1093\/hmg\/ddz187","article-title":"Towards clinical utility of polygenic risk scores","volume":"28","author":"Lambert","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/PO.19.00360","article-title":"Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk","volume":"4","author":"Hughes","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1001\/jama.2019.3893","article-title":"What Are Polygenic Scores and Why Are They Important?","volume":"321","author":"Sugrue","year":"2019","journal-title":"JAMA"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, R., Zhang, X., Li, B., Feng, Q., Kottyan, L., Luo, Y., Sawicki, K.T., Khan, A., Limdi, N., and Puckelwartz, M. (2022). Polygenic risk vectors (PRV) improve genetic risk stratification for cardio-metabolic diseases. medRxiv.","DOI":"10.1101\/2022.03.02.22271425"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ng.668","article-title":"A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24","volume":"42","author":"Goode","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1093\/hmg\/ddp295","article-title":"Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk","volume":"18","author":"Evans","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1158\/1055-9965.EPI-18-0833","article-title":"Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk","volume":"28","author":"Reid","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"pkaa021","DOI":"10.1093\/jncics\/pkaa021","article-title":"Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers","volume":"4","author":"Jia","year":"2020","journal-title":"JNCI Cancer Spectr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41431-021-00987-7","article-title":"Polygenic risk modeling for prediction of epithelial ovarian cancer risk","volume":"30","author":"Dareng","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex dis-eases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrg2809","article-title":"Missing heritability and strategies for finding the underlying causes of complex disease","volume":"11","author":"Eichler","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00439-019-02034-4","article-title":"Missing heritability of complex diseases: Case solved?","volume":"139","year":"2020","journal-title":"Hum. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1073\/pnas.1119675109","article-title":"The mystery of missing heritability: Genetic interactions create phantom heritability","volume":"109","author":"Zuk","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13040-021-00253-y","article-title":"Genetic risk score for ovarian cancer based on chromosomal-scale length variation","volume":"14","author":"Toh","year":"2021","journal-title":"BioData Min."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jain, S., Mazaheri, B., Raviv, N., and Bruck, J. (2019). Short Tandem Repeats Information in TCGA is Statistically Biased by Amplification. bioRxiv.","DOI":"10.1101\/518878"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jain, S., Mazaheri, B., Raviv, N., and Bruck, J. (2021). Glioblastoma signature in the DNA of blood-derived cells. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0256831"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/3\/762\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:59:38Z","timestamp":1760122778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/3\/762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["genes14030762"],"URL":"https:\/\/doi.org\/10.3390\/genes14030762","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]}}}